David Collier DavidACollier

New target identification using genetics, genomics, bioinformatics and network biology in neurodegeneration and psychiatry. Target annotation and ranking. RNAseq, array expression and epigenetic analysis of human brain. eQTLs. Genetic mapping. Systems biology approaches to understanding biological networks in brain disorders. Cheminformatics. Drug discovery using network-based gene expression changes to generate drug signatures. Pharmacoepidemiology and real world evidence data mining in drug discovery.

Windlesham, United Kingdom

Research Fellow

Pharmaceutical

Eli Lilly and Company Ltd

David Collier (DavidACollier) page is loading…